Table 2

Patient characteristics at baseline and for the sample with at least one follow-up measurement

Total sample (n=149)Sample with at least one follow-up (n=121)Mean difference (95% CI)
Age (y)52.68±9.35 (51.11 to 54.24)52.76±8.13 (51.35 to 54.17)−0.08 (–2.26 to 2.09)
Female gender98 (65.77%)77 (63.64%)NA
Height (cm)168.13±8.68 (166.77 to 169.49)168.64±8.16 (167.21 to 170.07)−0.51 (–2.60 to 1.57)
Weight (kg)70.60±14.44 (68.27 to 72.93)70.58±13.94 (68.09 to 73.08)0.02 (–3.41 to 3.44)
BMI (kg/cm2)24.73±3.97 (24.11 to 25.35)24.54±3.94 (23.85 to 25.22)0.20 (–0.79 to 1.18)
Hand dominance (right)121 (82.88%)97 (82.20%)NA
Affected side (right)70 (47.95%)52 (44.07%)NA
Affected side (dominant)75 (52.08%)55 (47.41%)NA
Cause (idiopathic FS)95 (63.7%)80 (66.12%)NA
Diabetes mellitus (yes)20 (13.51%)15 (12.50%)NA
Thyroid disorder (yes)13 (8.84%)12 (10.00%)NA
WorkNA
 No70 (47.62%)54 (45.38%)
 Part time28 (19.05%)22 (18.49%)
 Full time49 (33.33%)43 (36.13%)
Sport (yes)61 (42.07%)48 (41.03%)NA
Shoulder pain and disability (SPADI, 0–100)60.75±21.16 (57.46 to 64.05)60.20±25.10 (56.54 to 63.87)0.55 (–4.65 to 5.75)
Pain intensity during last 24 hours (VAS, 0–100)48.68±27.77 (44.17 to 53.19)46.81±27.85 (41.82 to 51.81)2.07 (–5.20 to 9.33)
Quality of life (SF-36, 0–100)
 Physical functioning67.88±19.16 (65.41 to 70.35)68.44±18.98 (65.65 to 71.23)−0.56 (–6.25 to 5.13)
 Social64.08±22.57 (61.17 to 67.00)63.43±21.81 (60.22 to 66.63)0.65 (–5.96 to 7.27)
 Physical problems22.63±32.22 (18.47 to 26.79)23.77±32.33 (19.01 to 28.52)−1.13 (–10.77 to 8.50)
 Emotional problems70.18±41.96 (64.76 to 75.59)72.02±41.32 (65.94 to 78.09)−1.84 (–14.26 to 10.58)
 Mental health64.97±17.16 (62.75 to 67.18)65.14±17.24 (62.60 to 67.67)−0.17 (–5.30 to 4.97)
 Vitality50.32±20.56 (47.66 to 52.97)50.99±20.45 (47.98 to 53.99)−0.67 (–6.79 to 5.45)
 Pain42.17±23.93 (39.09 to 45.26)41.43±23.16 (38.03 to 44.84)0.74 (–6.28 to 7.76)
 General health58.54±22.04 (55.69 to 61.38)58.53±21.68 (55.34 to 61.72)0.01 (–6.52 to 6.53)
Autonomic symptoms (COMPASS 31, 0–100)17.40±12.46 (15.45 to 19.36)17.36±12.37 (15.18 to 19.54)0.05 (–3.02 to 3.12)
Shoulder active ROM
 External rotation (0° abduction)12.29±15.79 (9.75 to 14.83)12.36±15.22 (9.63 to 15.08)−0.07 (–3.82 to 3.68)
 Flexion106.50±30.00 (101.68 to 111.32)105.99±28.56 (100.87 to 111.11)0.51 (–6.57 to 7.59)
 Abduction77.80±30.21 (72.95 to 82.64)77.29±29.09 (72.10 to 82.49)0.50 (–6.70 to 7.70)
PPT shoulder3.97±2.72 (3.53 to 4.41)3.90±2.64 (3.43 to 4.38)0.06 (–0.58 to 0.71)
PPT quadriceps7.09±5.81 (6.15 to 8.03)7.00±5.16 (6.05 to 7.91)0.11 (–1.21 to 1.42)
Temporal summation1.50±1.94 (1.19 to 1.82)1.59±1.95 (1.24 to 1.94)−0.08 (–0.55 to 0.39)
CPM−0.14±0.33 (–0.20 to –0.09)−0.15±0.30 (–0.21 to –0.10)0.002 (–0.07 to 0.08)
Treatment received
 None7 (6.36%)
 Invasive treatment (including CSI)11 (10.00%)
 Physical therapy46 (41.82%)
 Pharmacotherapy3 (2.73%)
 Physical therapy and pharmacotherapy3 (2.73%)
 Invasive and physical therapy24 (21.82%)
 Invasive and physical therapy and pharmacotherapy6 (5.45%)
 Alternative treatment (eg, osteopathy)2 (1.82%)
 Invasive and physical therapy and alternative treatment1 (0.91%)
 Physical therapy and alternative treatment6 (5.45%)
 Invasive and physical therapy and acute pain service1 (0.91%)
  • Mean±SD (95% CI) or frequencies (percentage) are presented.

  • BMI, body mass index; COMPASS-31, Composite Autonomic Symptom Score 31; CPM, conditioned pain modulation; CSI, corticosteroid injection; FS, frozen shoulder; NA, not available; PPT, pressure pain threshold; ROM, range of motion; SF-36, 36-item Short Form Health Survey; SPADI, Shoulder Pain and Disability Index; VAS, Visual Analogue Scale.